nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP2D6—Lomustine—brain cancer	0.0769	0.253	CbGbCtD
Risperidone—CYP2D6—Hydroxyurea—brain cancer	0.0583	0.192	CbGbCtD
Risperidone—CYP3A4—Temozolomide—brain cancer	0.0575	0.19	CbGbCtD
Risperidone—CYP3A4—Lomustine—brain cancer	0.0489	0.161	CbGbCtD
Risperidone—CYP3A5—Etoposide—brain cancer	0.0303	0.0999	CbGbCtD
Risperidone—ABCB1—Etoposide—brain cancer	0.0197	0.065	CbGbCtD
Risperidone—HTR1D—meninx—brain cancer	0.0156	0.0611	CbGeAlD
Risperidone—HTR1B—dura mater—brain cancer	0.0149	0.0581	CbGeAlD
Risperidone—HTR1D—dura mater—brain cancer	0.0144	0.0563	CbGeAlD
Risperidone—HTR2C—choroid plexus—brain cancer	0.0121	0.0474	CbGeAlD
Risperidone—CYP3A4—Etoposide—brain cancer	0.0118	0.0389	CbGbCtD
Risperidone—HTR1B—trigeminal nerve—brain cancer	0.00639	0.025	CbGeAlD
Risperidone—DRD3—telencephalic ventricle—brain cancer	0.00639	0.0249	CbGeAlD
Risperidone—HTR1D—trigeminal nerve—brain cancer	0.00619	0.0242	CbGeAlD
Risperidone—HTR2A—choroid plexus—brain cancer	0.00608	0.0238	CbGeAlD
Risperidone—HRH1—nose—brain cancer	0.00469	0.0183	CbGeAlD
Risperidone—DRD1—telencephalic ventricle—brain cancer	0.00457	0.0179	CbGeAlD
Risperidone—HTR1B—cranial nerve—brain cancer	0.00456	0.0178	CbGeAlD
Risperidone—HTR7—vein—brain cancer	0.00446	0.0174	CbGeAlD
Risperidone—HTR1D—cranial nerve—brain cancer	0.00441	0.0172	CbGeAlD
Risperidone—HTR1B—telencephalic ventricle—brain cancer	0.0037	0.0145	CbGeAlD
Risperidone—HTR1D—telencephalic ventricle—brain cancer	0.00359	0.014	CbGeAlD
Risperidone—HTR2C—telencephalic ventricle—brain cancer	0.00355	0.0139	CbGeAlD
Risperidone—HTR7—cranial nerve—brain cancer	0.00351	0.0137	CbGeAlD
Risperidone—HTR7—pons—brain cancer	0.00347	0.0136	CbGeAlD
Risperidone—HTR2A—trigeminal nerve—brain cancer	0.00308	0.012	CbGeAlD
Risperidone—HTR2A—cerebellar cortex—brain cancer	0.00306	0.012	CbGeAlD
Risperidone—HTR1A—telencephalic ventricle—brain cancer	0.00299	0.0117	CbGeAlD
Risperidone—HTR7—telencephalic ventricle—brain cancer	0.00286	0.0112	CbGeAlD
Risperidone—DRD1—ganglion—brain cancer	0.00285	0.0111	CbGeAlD
Risperidone—HTR2A—vein—brain cancer	0.00278	0.0109	CbGeAlD
Risperidone—DRD2—telencephalic ventricle—brain cancer	0.0027	0.0106	CbGeAlD
Risperidone—HTR1B—ganglion—brain cancer	0.00231	0.00901	CbGeAlD
Risperidone—HTR1D—ganglion—brain cancer	0.00223	0.00872	CbGeAlD
Risperidone—HTR2C—ganglion—brain cancer	0.00221	0.00864	CbGeAlD
Risperidone—HTR2A—cranial nerve—brain cancer	0.00219	0.00856	CbGeAlD
Risperidone—HTR2A—pons—brain cancer	0.00217	0.00846	CbGeAlD
Risperidone—HTR1A—ganglion—brain cancer	0.00186	0.00727	CbGeAlD
Risperidone—HTR1B—blood vessel—brain cancer	0.00183	0.00717	CbGeAlD
Risperidone—HTR2A—telencephalic ventricle—brain cancer	0.00178	0.00696	CbGeAlD
Risperidone—HTR7—ganglion—brain cancer	0.00178	0.00695	CbGeAlD
Risperidone—HTR1D—blood vessel—brain cancer	0.00178	0.00694	CbGeAlD
Risperidone—DRD2—ganglion—brain cancer	0.00168	0.00657	CbGeAlD
Risperidone—HTR2A—pineal body—brain cancer	0.00155	0.00604	CbGeAlD
Risperidone—HTR7—endothelium—brain cancer	0.00153	0.00599	CbGeAlD
Risperidone—HTR7—blood vessel—brain cancer	0.00141	0.00553	CbGeAlD
Risperidone—HTR1A—hindbrain—brain cancer	0.00141	0.00551	CbGeAlD
Risperidone—HTR7—hindbrain—brain cancer	0.00135	0.00527	CbGeAlD
Risperidone—ADRA1A—hindbrain—brain cancer	0.0013	0.00508	CbGeAlD
Risperidone—DRD2—hindbrain—brain cancer	0.00128	0.00498	CbGeAlD
Risperidone—DRD1—brainstem—brain cancer	0.00124	0.00483	CbGeAlD
Risperidone—H1F0—telencephalon—brain cancer	0.00111	0.00434	CbGeAlD
Risperidone—HTR2A—ganglion—brain cancer	0.00111	0.00433	CbGeAlD
Risperidone—DRD1—telencephalon—brain cancer	0.0011	0.00429	CbGeAlD
Risperidone—HTR1B—brainstem—brain cancer	0.001	0.00392	CbGeAlD
Risperidone—DRD4—brain—brain cancer	0.000984	0.00385	CbGeAlD
Risperidone—HTR1D—brainstem—brain cancer	0.00097	0.00379	CbGeAlD
Risperidone—HTR2C—brainstem—brain cancer	0.000961	0.00376	CbGeAlD
Risperidone—HTR2A—endothelium—brain cancer	0.000956	0.00374	CbGeAlD
Risperidone—DRD3—head—brain cancer	0.000955	0.00373	CbGeAlD
Risperidone—CYP3A7—endocrine gland—brain cancer	0.000946	0.0037	CbGeAlD
Risperidone—H1F0—gonad—brain cancer	0.000928	0.00363	CbGeAlD
Risperidone—H1F0—pituitary gland—brain cancer	0.000905	0.00354	CbGeAlD
Risperidone—HTR1B—telencephalon—brain cancer	0.00089	0.00348	CbGeAlD
Risperidone—HTR2A—blood vessel—brain cancer	0.000882	0.00345	CbGeAlD
Risperidone—H1F0—medulla oblongata—brain cancer	0.000874	0.00341	CbGeAlD
Risperidone—DRD3—central nervous system—brain cancer	0.000871	0.00341	CbGeAlD
Risperidone—HTR1D—telencephalon—brain cancer	0.000861	0.00337	CbGeAlD
Risperidone—HTR2C—telencephalon—brain cancer	0.000853	0.00333	CbGeAlD
Risperidone—HTR2A—hindbrain—brain cancer	0.000841	0.00329	CbGeAlD
Risperidone—HTR1A—brainstem—brain cancer	0.000809	0.00316	CbGeAlD
Risperidone—HTR2B—telencephalon—brain cancer	0.000801	0.00313	CbGeAlD
Risperidone—H1F0—midbrain—brain cancer	0.000798	0.00312	CbGeAlD
Risperidone—DRD1—midbrain—brain cancer	0.000788	0.00308	CbGeAlD
Risperidone—H1F0—spinal cord—brain cancer	0.000779	0.00304	CbGeAlD
Risperidone—HTR7—brainstem—brain cancer	0.000773	0.00302	CbGeAlD
Risperidone—CYP2D6—hindbrain—brain cancer	0.000766	0.00299	CbGeAlD
Risperidone—ADRA1A—brainstem—brain cancer	0.000746	0.00291	CbGeAlD
Risperidone—ADRA1B—head—brain cancer	0.000733	0.00287	CbGeAlD
Risperidone—DRD2—brainstem—brain cancer	0.000731	0.00286	CbGeAlD
Risperidone—HTR1A—telencephalon—brain cancer	0.000718	0.00281	CbGeAlD
Risperidone—H1F0—endocrine gland—brain cancer	0.000701	0.00274	CbGeAlD
Risperidone—H1F0—head—brain cancer	0.000692	0.00271	CbGeAlD
Risperidone—DRD3—brain—brain cancer	0.000692	0.0027	CbGeAlD
Risperidone—HTR7—telencephalon—brain cancer	0.000686	0.00268	CbGeAlD
Risperidone—DRD1—head—brain cancer	0.000684	0.00267	CbGeAlD
Risperidone—HTR2C—medulla oblongata—brain cancer	0.00067	0.00262	CbGeAlD
Risperidone—ADRA1B—central nervous system—brain cancer	0.000669	0.00262	CbGeAlD
Risperidone—ADRA1A—telencephalon—brain cancer	0.000662	0.00259	CbGeAlD
Risperidone—DRD2—telencephalon—brain cancer	0.000649	0.00253	CbGeAlD
Risperidone—KCNH2—telencephalon—brain cancer	0.000639	0.0025	CbGeAlD
Risperidone—HTR1B—midbrain—brain cancer	0.000639	0.0025	CbGeAlD
Risperidone—H1F0—central nervous system—brain cancer	0.000632	0.00247	CbGeAlD
Risperidone—ADRA2C—telencephalon—brain cancer	0.000631	0.00246	CbGeAlD
Risperidone—DRD1—central nervous system—brain cancer	0.000624	0.00244	CbGeAlD
Risperidone—HTR1B—spinal cord—brain cancer	0.000623	0.00244	CbGeAlD
Risperidone—HTR1D—midbrain—brain cancer	0.000618	0.00242	CbGeAlD
Risperidone—H1F0—cerebellum—brain cancer	0.000618	0.00241	CbGeAlD
Risperidone—HTR2C—midbrain—brain cancer	0.000612	0.00239	CbGeAlD
Risperidone—HTR2C—spinal cord—brain cancer	0.000598	0.00233	CbGeAlD
Risperidone—ABCB1—blood vessel—brain cancer	0.000578	0.00226	CbGeAlD
Risperidone—HTR7—gonad—brain cancer	0.000573	0.00224	CbGeAlD
Risperidone—HTR1B—endocrine gland—brain cancer	0.000561	0.00219	CbGeAlD
Risperidone—HTR1B—head—brain cancer	0.000554	0.00216	CbGeAlD
Risperidone—HTR7—medulla oblongata—brain cancer	0.000539	0.00211	CbGeAlD
Risperidone—HTR1D—head—brain cancer	0.000536	0.0021	CbGeAlD
Risperidone—ADRA1B—brain—brain cancer	0.000532	0.00208	CbGeAlD
Risperidone—HTR2C—head—brain cancer	0.000531	0.00208	CbGeAlD
Risperidone—DRD2—pituitary gland—brain cancer	0.000528	0.00206	CbGeAlD
Risperidone—KCNH2—pituitary gland—brain cancer	0.00052	0.00203	CbGeAlD
Risperidone—HTR1A—midbrain—brain cancer	0.000516	0.00201	CbGeAlD
Risperidone—ADRA2C—pituitary gland—brain cancer	0.000513	0.00201	CbGeAlD
Risperidone—HRH1—telencephalon—brain cancer	0.000512	0.002	CbGeAlD
Risperidone—HTR1B—central nervous system—brain cancer	0.000506	0.00198	CbGeAlD
Risperidone—ADRA2A—telencephalon—brain cancer	0.000503	0.00197	CbGeAlD
Risperidone—HTR1A—spinal cord—brain cancer	0.000503	0.00197	CbGeAlD
Risperidone—KCNH2—medulla oblongata—brain cancer	0.000502	0.00196	CbGeAlD
Risperidone—H1F0—brain—brain cancer	0.000502	0.00196	CbGeAlD
Risperidone—HTR2B—head—brain cancer	0.000499	0.00195	CbGeAlD
Risperidone—ADRA2C—medulla oblongata—brain cancer	0.000495	0.00194	CbGeAlD
Risperidone—DRD1—brain—brain cancer	0.000495	0.00194	CbGeAlD
Risperidone—HTR7—midbrain—brain cancer	0.000493	0.00193	CbGeAlD
Risperidone—HTR1D—central nervous system—brain cancer	0.00049	0.00191	CbGeAlD
Risperidone—HTR2C—central nervous system—brain cancer	0.000485	0.00189	CbGeAlD
Risperidone—HTR2A—brainstem—brain cancer	0.000482	0.00188	CbGeAlD
Risperidone—HTR7—spinal cord—brain cancer	0.000481	0.00188	CbGeAlD
Risperidone—DRD2—midbrain—brain cancer	0.000466	0.00182	CbGeAlD
Risperidone—KCNH2—midbrain—brain cancer	0.000459	0.00179	CbGeAlD
Risperidone—HTR2B—central nervous system—brain cancer	0.000455	0.00178	CbGeAlD
Risperidone—ADRA2C—midbrain—brain cancer	0.000453	0.00177	CbGeAlD
Risperidone—HTR1A—endocrine gland—brain cancer	0.000453	0.00177	CbGeAlD
Risperidone—KCNH2—spinal cord—brain cancer	0.000448	0.00175	CbGeAlD
Risperidone—HTR1A—head—brain cancer	0.000447	0.00175	CbGeAlD
Risperidone—ADRA2C—spinal cord—brain cancer	0.000442	0.00173	CbGeAlD
Risperidone—CYP2D6—brainstem—brain cancer	0.000439	0.00172	CbGeAlD
Risperidone—HTR7—endocrine gland—brain cancer	0.000433	0.00169	CbGeAlD
Risperidone—HTR2A—telencephalon—brain cancer	0.000428	0.00167	CbGeAlD
Risperidone—HTR7—head—brain cancer	0.000427	0.00167	CbGeAlD
Risperidone—ADRA2A—gonad—brain cancer	0.00042	0.00164	CbGeAlD
Risperidone—ADRA1A—endocrine gland—brain cancer	0.000417	0.00163	CbGeAlD
Risperidone—ADRA1A—head—brain cancer	0.000412	0.00161	CbGeAlD
Risperidone—ADRA2A—pituitary gland—brain cancer	0.00041	0.0016	CbGeAlD
Risperidone—DRD2—endocrine gland—brain cancer	0.000409	0.0016	CbGeAlD
Risperidone—HTR1A—central nervous system—brain cancer	0.000408	0.00159	CbGeAlD
Risperidone—DRD2—head—brain cancer	0.000404	0.00158	CbGeAlD
Risperidone—KCNH2—endocrine gland—brain cancer	0.000403	0.00158	CbGeAlD
Risperidone—HTR1B—brain—brain cancer	0.000401	0.00157	CbGeAlD
Risperidone—HTR1A—cerebellum—brain cancer	0.000399	0.00156	CbGeAlD
Risperidone—KCNH2—head—brain cancer	0.000398	0.00156	CbGeAlD
Risperidone—ADRA2A—medulla oblongata—brain cancer	0.000395	0.00154	CbGeAlD
Risperidone—ADRA2C—head—brain cancer	0.000393	0.00153	CbGeAlD
Risperidone—HTR7—central nervous system—brain cancer	0.00039	0.00152	CbGeAlD
Risperidone—CYP2D6—telencephalon—brain cancer	0.00039	0.00152	CbGeAlD
Risperidone—HTR1D—brain—brain cancer	0.000389	0.00152	CbGeAlD
Risperidone—HTR2C—brain—brain cancer	0.000385	0.0015	CbGeAlD
Risperidone—HTR7—cerebellum—brain cancer	0.000381	0.00149	CbGeAlD
Risperidone—ADRA1A—central nervous system—brain cancer	0.000376	0.00147	CbGeAlD
Risperidone—DRD2—central nervous system—brain cancer	0.000369	0.00144	CbGeAlD
Risperidone—Fatigue—Procarbazine—brain cancer	0.000368	0.0011	CcSEcCtD
Risperidone—ADRA1A—cerebellum—brain cancer	0.000368	0.00144	CbGeAlD
Risperidone—Haemoglobin—Temozolomide—brain cancer	0.000365	0.00109	CcSEcCtD
Risperidone—Malaise—Hydroxyurea—brain cancer	0.000365	0.00109	CcSEcCtD
Risperidone—Pain—Procarbazine—brain cancer	0.000365	0.00109	CcSEcCtD
Risperidone—Constipation—Procarbazine—brain cancer	0.000365	0.00109	CcSEcCtD
Risperidone—KCNH2—central nervous system—brain cancer	0.000363	0.00142	CbGeAlD
Risperidone—Haemorrhage—Temozolomide—brain cancer	0.000363	0.00108	CcSEcCtD
Risperidone—Hepatitis—Temozolomide—brain cancer	0.000363	0.00108	CcSEcCtD
Risperidone—Dysphagia—Etoposide—brain cancer	0.000363	0.00108	CcSEcCtD
Risperidone—Leukopenia—Hydroxyurea—brain cancer	0.000362	0.00108	CcSEcCtD
Risperidone—Visual impairment—Carmustine—brain cancer	0.000362	0.00108	CcSEcCtD
Risperidone—HTR2B—brain—brain cancer	0.000362	0.00141	CbGeAlD
Risperidone—ADRA2A—midbrain—brain cancer	0.000361	0.00141	CbGeAlD
Risperidone—Hypoaesthesia—Temozolomide—brain cancer	0.000361	0.00108	CcSEcCtD
Risperidone—DRD2—cerebellum—brain cancer	0.00036	0.00141	CbGeAlD
Risperidone—Pharyngitis—Temozolomide—brain cancer	0.00036	0.00107	CcSEcCtD
Risperidone—Urinary tract disorder—Temozolomide—brain cancer	0.000359	0.00107	CcSEcCtD
Risperidone—ADRA2C—central nervous system—brain cancer	0.000358	0.0014	CbGeAlD
Risperidone—Oedema peripheral—Temozolomide—brain cancer	0.000358	0.00107	CcSEcCtD
Risperidone—HTR2A—gonad—brain cancer	0.000357	0.0014	CbGeAlD
Risperidone—Bronchospasm—Etoposide—brain cancer	0.000357	0.00106	CcSEcCtD
Risperidone—Connective tissue disorder—Temozolomide—brain cancer	0.000357	0.00106	CcSEcCtD
Risperidone—Urethral disorder—Temozolomide—brain cancer	0.000356	0.00106	CcSEcCtD
Risperidone—KCNH2—cerebellum—brain cancer	0.000355	0.00139	CbGeAlD
Risperidone—Sweating increased—Etoposide—brain cancer	0.000354	0.00105	CcSEcCtD
Risperidone—ADRA2A—spinal cord—brain cancer	0.000353	0.00138	CbGeAlD
Risperidone—Feeling abnormal—Procarbazine—brain cancer	0.000352	0.00105	CcSEcCtD
Risperidone—Eye disorder—Carmustine—brain cancer	0.000351	0.00105	CcSEcCtD
Risperidone—Convulsion—Hydroxyurea—brain cancer	0.00035	0.00105	CcSEcCtD
Risperidone—ADRA2C—cerebellum—brain cancer	0.00035	0.00137	CbGeAlD
Risperidone—Visual impairment—Temozolomide—brain cancer	0.00035	0.00104	CcSEcCtD
Risperidone—Gastrointestinal pain—Procarbazine—brain cancer	0.000349	0.00104	CcSEcCtD
Risperidone—Flushing—Carmustine—brain cancer	0.000349	0.00104	CcSEcCtD
Risperidone—HTR2A—pituitary gland—brain cancer	0.000348	0.00136	CbGeAlD
Risperidone—Erythema multiforme—Temozolomide—brain cancer	0.000343	0.00102	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000342	0.00102	CcSEcCtD
Risperidone—Discomfort—Hydroxyurea—brain cancer	0.00034	0.00101	CcSEcCtD
Risperidone—Neutropenia—Etoposide—brain cancer	0.000339	0.00101	CcSEcCtD
Risperidone—Eye disorder—Temozolomide—brain cancer	0.000339	0.00101	CcSEcCtD
Risperidone—Urticaria—Procarbazine—brain cancer	0.000339	0.00101	CcSEcCtD
Risperidone—Tinnitus—Temozolomide—brain cancer	0.000338	0.00101	CcSEcCtD
Risperidone—Body temperature increased—Procarbazine—brain cancer	0.000337	0.00101	CcSEcCtD
Risperidone—Abdominal pain—Procarbazine—brain cancer	0.000337	0.00101	CcSEcCtD
Risperidone—Flushing—Temozolomide—brain cancer	0.000337	0.001	CcSEcCtD
Risperidone—Cardiac disorder—Temozolomide—brain cancer	0.000337	0.001	CcSEcCtD
Risperidone—HTR2A—medulla oblongata—brain cancer	0.000336	0.00131	CbGeAlD
Risperidone—Arrhythmia—Carmustine—brain cancer	0.000336	0.001	CcSEcCtD
Risperidone—CYP3A5—endocrine gland—brain cancer	0.000333	0.0013	CbGeAlD
Risperidone—Alopecia—Carmustine—brain cancer	0.000332	0.00099	CcSEcCtD
Risperidone—Oedema—Hydroxyurea—brain cancer	0.00033	0.000985	CcSEcCtD
Risperidone—Angiopathy—Temozolomide—brain cancer	0.000329	0.000982	CcSEcCtD
Risperidone—Mental disorder—Carmustine—brain cancer	0.000329	0.000981	CcSEcCtD
Risperidone—Infection—Hydroxyurea—brain cancer	0.000328	0.000978	CcSEcCtD
Risperidone—Immune system disorder—Temozolomide—brain cancer	0.000328	0.000978	CcSEcCtD
Risperidone—Mediastinal disorder—Temozolomide—brain cancer	0.000327	0.000976	CcSEcCtD
Risperidone—Erythema—Carmustine—brain cancer	0.000327	0.000975	CcSEcCtD
Risperidone—Malnutrition—Carmustine—brain cancer	0.000327	0.000975	CcSEcCtD
Risperidone—Chills—Temozolomide—brain cancer	0.000326	0.000971	CcSEcCtD
Risperidone—Pneumonia—Etoposide—brain cancer	0.000325	0.000971	CcSEcCtD
Risperidone—HTR1A—brain—brain cancer	0.000324	0.00127	CbGeAlD
Risperidone—Nervous system disorder—Hydroxyurea—brain cancer	0.000324	0.000966	CcSEcCtD
Risperidone—Infestation NOS—Etoposide—brain cancer	0.000324	0.000965	CcSEcCtD
Risperidone—Infestation—Etoposide—brain cancer	0.000324	0.000965	CcSEcCtD
Risperidone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000323	0.000964	CcSEcCtD
Risperidone—HRH1—endocrine gland—brain cancer	0.000323	0.00126	CbGeAlD
Risperidone—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000321	0.000957	CcSEcCtD
Risperidone—Alopecia—Temozolomide—brain cancer	0.000321	0.000957	CcSEcCtD
Risperidone—Skin disorder—Hydroxyurea—brain cancer	0.000321	0.000956	CcSEcCtD
Risperidone—Acute coronary syndrome—Etoposide—brain cancer	0.000319	0.000951	CcSEcCtD
Risperidone—HRH1—head—brain cancer	0.000319	0.00125	CbGeAlD
Risperidone—Renal failure—Etoposide—brain cancer	0.000318	0.000949	CcSEcCtD
Risperidone—Mental disorder—Temozolomide—brain cancer	0.000318	0.000948	CcSEcCtD
Risperidone—ADRA2A—endocrine gland—brain cancer	0.000317	0.00124	CbGeAlD
Risperidone—Myocardial infarction—Etoposide—brain cancer	0.000317	0.000946	CcSEcCtD
Risperidone—Neuropathy peripheral—Etoposide—brain cancer	0.000317	0.000946	CcSEcCtD
Risperidone—Back pain—Carmustine—brain cancer	0.000316	0.000943	CcSEcCtD
Risperidone—Malnutrition—Temozolomide—brain cancer	0.000316	0.000942	CcSEcCtD
Risperidone—Erythema—Temozolomide—brain cancer	0.000316	0.000942	CcSEcCtD
Risperidone—Stomatitis—Etoposide—brain cancer	0.000315	0.000941	CcSEcCtD
Risperidone—Jaundice—Etoposide—brain cancer	0.000315	0.000941	CcSEcCtD
Risperidone—Anorexia—Hydroxyurea—brain cancer	0.000315	0.000938	CcSEcCtD
Risperidone—Hypersensitivity—Procarbazine—brain cancer	0.000314	0.000937	CcSEcCtD
Risperidone—ADRA2A—head—brain cancer	0.000313	0.00122	CbGeAlD
Risperidone—HTR7—brain—brain cancer	0.00031	0.00121	CbGeAlD
Risperidone—Dysgeusia—Temozolomide—brain cancer	0.000309	0.000923	CcSEcCtD
Risperidone—Vision blurred—Carmustine—brain cancer	0.000308	0.000919	CcSEcCtD
Risperidone—HTR2A—midbrain—brain cancer	0.000307	0.0012	CbGeAlD
Risperidone—Tremor—Carmustine—brain cancer	0.000306	0.000914	CcSEcCtD
Risperidone—Asthenia—Procarbazine—brain cancer	0.000306	0.000913	CcSEcCtD
Risperidone—Hepatobiliary disease—Etoposide—brain cancer	0.000306	0.000913	CcSEcCtD
Risperidone—Back pain—Temozolomide—brain cancer	0.000306	0.000912	CcSEcCtD
Risperidone—Anaemia—Carmustine—brain cancer	0.000302	0.000901	CcSEcCtD
Risperidone—Agranulocytosis—Etoposide—brain cancer	0.000302	0.000901	CcSEcCtD
Risperidone—Pruritus—Procarbazine—brain cancer	0.000302	0.0009	CcSEcCtD
Risperidone—Agitation—Carmustine—brain cancer	0.000301	0.000896	CcSEcCtD
Risperidone—HTR2A—spinal cord—brain cancer	0.0003	0.00117	CbGeAlD
Risperidone—ADRA1A—brain—brain cancer	0.000299	0.00117	CbGeAlD
Risperidone—Vision blurred—Temozolomide—brain cancer	0.000298	0.000888	CcSEcCtD
Risperidone—Tremor—Temozolomide—brain cancer	0.000296	0.000883	CcSEcCtD
Risperidone—Dyspnoea—Hydroxyurea—brain cancer	0.000294	0.000878	CcSEcCtD
Risperidone—Somnolence—Hydroxyurea—brain cancer	0.000293	0.000875	CcSEcCtD
Risperidone—Ill-defined disorder—Temozolomide—brain cancer	0.000293	0.000874	CcSEcCtD
Risperidone—Leukopenia—Carmustine—brain cancer	0.000293	0.000873	CcSEcCtD
Risperidone—DRD2—brain—brain cancer	0.000293	0.00114	CbGeAlD
Risperidone—Anaemia—Temozolomide—brain cancer	0.000292	0.000871	CcSEcCtD
Risperidone—Diarrhoea—Procarbazine—brain cancer	0.000292	0.00087	CcSEcCtD
Risperidone—HRH1—central nervous system—brain cancer	0.000291	0.00114	CbGeAlD
Risperidone—Dyspepsia—Hydroxyurea—brain cancer	0.000291	0.000867	CcSEcCtD
Risperidone—Agitation—Temozolomide—brain cancer	0.00029	0.000866	CcSEcCtD
Risperidone—Hypoaesthesia—Etoposide—brain cancer	0.000289	0.000862	CcSEcCtD
Risperidone—Angioedema—Temozolomide—brain cancer	0.000289	0.000861	CcSEcCtD
Risperidone—KCNH2—brain—brain cancer	0.000288	0.00113	CbGeAlD
Risperidone—Decreased appetite—Hydroxyurea—brain cancer	0.000287	0.000856	CcSEcCtD
Risperidone—Urinary tract disorder—Etoposide—brain cancer	0.000287	0.000856	CcSEcCtD
Risperidone—ADRA2A—central nervous system—brain cancer	0.000286	0.00112	CbGeAlD
Risperidone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000285	0.00085	CcSEcCtD
Risperidone—Malaise—Temozolomide—brain cancer	0.000285	0.00085	CcSEcCtD
Risperidone—Urethral disorder—Etoposide—brain cancer	0.000285	0.000849	CcSEcCtD
Risperidone—Fatigue—Hydroxyurea—brain cancer	0.000285	0.000849	CcSEcCtD
Risperidone—ADRA2C—brain—brain cancer	0.000285	0.00111	CbGeAlD
Risperidone—Vertigo—Temozolomide—brain cancer	0.000284	0.000847	CcSEcCtD
Risperidone—Convulsion—Carmustine—brain cancer	0.000283	0.000845	CcSEcCtD
Risperidone—Leukopenia—Temozolomide—brain cancer	0.000283	0.000844	CcSEcCtD
Risperidone—Hypertension—Carmustine—brain cancer	0.000282	0.000842	CcSEcCtD
Risperidone—Constipation—Hydroxyurea—brain cancer	0.000282	0.000842	CcSEcCtD
Risperidone—Pain—Hydroxyurea—brain cancer	0.000282	0.000842	CcSEcCtD
Risperidone—Dizziness—Procarbazine—brain cancer	0.000282	0.000841	CcSEcCtD
Risperidone—ABCB1—telencephalon—brain cancer	0.00028	0.0011	CbGeAlD
Risperidone—ADRA2A—cerebellum—brain cancer	0.00028	0.00109	CbGeAlD
Risperidone—Palpitations—Temozolomide—brain cancer	0.000279	0.000833	CcSEcCtD
Risperidone—Chest pain—Carmustine—brain cancer	0.000278	0.00083	CcSEcCtD
Risperidone—Myalgia—Carmustine—brain cancer	0.000278	0.00083	CcSEcCtD
Risperidone—Anxiety—Carmustine—brain cancer	0.000277	0.000827	CcSEcCtD
Risperidone—Cough—Temozolomide—brain cancer	0.000276	0.000822	CcSEcCtD
Risperidone—Erythema multiforme—Etoposide—brain cancer	0.000275	0.000819	CcSEcCtD
Risperidone—Convulsion—Temozolomide—brain cancer	0.000274	0.000817	CcSEcCtD
Risperidone—Hypertension—Temozolomide—brain cancer	0.000273	0.000814	CcSEcCtD
Risperidone—Feeling abnormal—Hydroxyurea—brain cancer	0.000272	0.000811	CcSEcCtD
Risperidone—Eye disorder—Etoposide—brain cancer	0.000271	0.00081	CcSEcCtD
Risperidone—Vomiting—Procarbazine—brain cancer	0.000271	0.000809	CcSEcCtD
Risperidone—HTR2A—endocrine gland—brain cancer	0.00027	0.00105	CbGeAlD
Risperidone—Flushing—Etoposide—brain cancer	0.00027	0.000804	CcSEcCtD
Risperidone—Cardiac disorder—Etoposide—brain cancer	0.00027	0.000804	CcSEcCtD
Risperidone—Confusional state—Carmustine—brain cancer	0.000269	0.000803	CcSEcCtD
Risperidone—Myalgia—Temozolomide—brain cancer	0.000269	0.000802	CcSEcCtD
Risperidone—Arthralgia—Temozolomide—brain cancer	0.000269	0.000802	CcSEcCtD
Risperidone—Rash—Procarbazine—brain cancer	0.000269	0.000802	CcSEcCtD
Risperidone—Dermatitis—Procarbazine—brain cancer	0.000269	0.000801	CcSEcCtD
Risperidone—Anxiety—Temozolomide—brain cancer	0.000268	0.0008	CcSEcCtD
Risperidone—Headache—Procarbazine—brain cancer	0.000267	0.000797	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000267	0.000797	CcSEcCtD
Risperidone—Oedema—Carmustine—brain cancer	0.000267	0.000796	CcSEcCtD
Risperidone—HTR2A—head—brain cancer	0.000266	0.00104	CbGeAlD
Risperidone—Discomfort—Temozolomide—brain cancer	0.000266	0.000793	CcSEcCtD
Risperidone—Infection—Carmustine—brain cancer	0.000265	0.000791	CcSEcCtD
Risperidone—Angiopathy—Etoposide—brain cancer	0.000264	0.000786	CcSEcCtD
Risperidone—Dry mouth—Temozolomide—brain cancer	0.000263	0.000785	CcSEcCtD
Risperidone—Immune system disorder—Etoposide—brain cancer	0.000262	0.000782	CcSEcCtD
Risperidone—Mediastinal disorder—Etoposide—brain cancer	0.000262	0.000781	CcSEcCtD
Risperidone—Thrombocytopenia—Carmustine—brain cancer	0.000261	0.000779	CcSEcCtD
Risperidone—Body temperature increased—Hydroxyurea—brain cancer	0.000261	0.000778	CcSEcCtD
Risperidone—Chills—Etoposide—brain cancer	0.000261	0.000777	CcSEcCtD
Risperidone—Tachycardia—Carmustine—brain cancer	0.00026	0.000777	CcSEcCtD
Risperidone—Confusional state—Temozolomide—brain cancer	0.00026	0.000776	CcSEcCtD
Risperidone—Oedema—Temozolomide—brain cancer	0.000258	0.000769	CcSEcCtD
Risperidone—Anaphylactic shock—Temozolomide—brain cancer	0.000258	0.000769	CcSEcCtD
Risperidone—Alopecia—Etoposide—brain cancer	0.000257	0.000766	CcSEcCtD
Risperidone—Infection—Temozolomide—brain cancer	0.000256	0.000764	CcSEcCtD
Risperidone—Anorexia—Carmustine—brain cancer	0.000254	0.000759	CcSEcCtD
Risperidone—Nausea—Procarbazine—brain cancer	0.000253	0.000756	CcSEcCtD
Risperidone—Nervous system disorder—Temozolomide—brain cancer	0.000253	0.000754	CcSEcCtD
Risperidone—Thrombocytopenia—Temozolomide—brain cancer	0.000253	0.000753	CcSEcCtD
Risperidone—Skin disorder—Temozolomide—brain cancer	0.000251	0.000747	CcSEcCtD
Risperidone—CYP3A4—endocrine gland—brain cancer	0.00025	0.000976	CbGeAlD
Risperidone—Hypotension—Carmustine—brain cancer	0.000249	0.000744	CcSEcCtD
Risperidone—Hyperhidrosis—Temozolomide—brain cancer	0.000249	0.000744	CcSEcCtD
Risperidone—Dysgeusia—Etoposide—brain cancer	0.000248	0.000738	CcSEcCtD
Risperidone—Anorexia—Temozolomide—brain cancer	0.000246	0.000733	CcSEcCtD
Risperidone—CYP2D6—endocrine gland—brain cancer	0.000246	0.000961	CbGeAlD
Risperidone—Back pain—Etoposide—brain cancer	0.000245	0.000729	CcSEcCtD
Risperidone—Hypersensitivity—Hydroxyurea—brain cancer	0.000243	0.000725	CcSEcCtD
Risperidone—HTR2A—central nervous system—brain cancer	0.000243	0.00095	CbGeAlD
Risperidone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000243	0.000725	CcSEcCtD
Risperidone—Muscle spasms—Etoposide—brain cancer	0.000243	0.000725	CcSEcCtD
Risperidone—CYP2D6—head—brain cancer	0.000243	0.000948	CbGeAlD
Risperidone—Insomnia—Carmustine—brain cancer	0.000241	0.00072	CcSEcCtD
Risperidone—Paraesthesia—Carmustine—brain cancer	0.00024	0.000715	CcSEcCtD
Risperidone—Dyspnoea—Carmustine—brain cancer	0.000238	0.00071	CcSEcCtD
Risperidone—HTR2A—cerebellum—brain cancer	0.000238	0.000929	CbGeAlD
Risperidone—Somnolence—Carmustine—brain cancer	0.000237	0.000708	CcSEcCtD
Risperidone—Asthenia—Hydroxyurea—brain cancer	0.000237	0.000706	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000235	0.000701	CcSEcCtD
Risperidone—Ill-defined disorder—Etoposide—brain cancer	0.000235	0.0007	CcSEcCtD
Risperidone—ABCB1—gonad—brain cancer	0.000234	0.000914	CbGeAlD
Risperidone—Anaemia—Etoposide—brain cancer	0.000234	0.000697	CcSEcCtD
Risperidone—Insomnia—Temozolomide—brain cancer	0.000233	0.000696	CcSEcCtD
Risperidone—Decreased appetite—Carmustine—brain cancer	0.000232	0.000692	CcSEcCtD
Risperidone—Paraesthesia—Temozolomide—brain cancer	0.000232	0.000691	CcSEcCtD
Risperidone—HRH1—brain—brain cancer	0.000231	0.000903	CbGeAlD
Risperidone—Gastrointestinal disorder—Carmustine—brain cancer	0.00023	0.000687	CcSEcCtD
Risperidone—Dyspnoea—Temozolomide—brain cancer	0.00023	0.000686	CcSEcCtD
Risperidone—Somnolence—Temozolomide—brain cancer	0.000229	0.000684	CcSEcCtD
Risperidone—ABCB1—pituitary gland—brain cancer	0.000228	0.000892	CbGeAlD
Risperidone—Pain—Carmustine—brain cancer	0.000228	0.000681	CcSEcCtD
Risperidone—Constipation—Carmustine—brain cancer	0.000228	0.000681	CcSEcCtD
Risperidone—Malaise—Etoposide—brain cancer	0.000228	0.00068	CcSEcCtD
Risperidone—Vertigo—Etoposide—brain cancer	0.000227	0.000678	CcSEcCtD
Risperidone—ADRA2A—brain—brain cancer	0.000227	0.000887	CbGeAlD
Risperidone—Dyspepsia—Temozolomide—brain cancer	0.000227	0.000677	CcSEcCtD
Risperidone—Leukopenia—Etoposide—brain cancer	0.000226	0.000675	CcSEcCtD
Risperidone—Diarrhoea—Hydroxyurea—brain cancer	0.000226	0.000674	CcSEcCtD
Risperidone—CYP3A4—central nervous system—brain cancer	0.000225	0.00088	CbGeAlD
Risperidone—Decreased appetite—Temozolomide—brain cancer	0.000224	0.000669	CcSEcCtD
Risperidone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000223	0.000664	CcSEcCtD
Risperidone—Fatigue—Temozolomide—brain cancer	0.000222	0.000663	CcSEcCtD
Risperidone—Loss of consciousness—Etoposide—brain cancer	0.000222	0.000663	CcSEcCtD
Risperidone—CYP2D6—central nervous system—brain cancer	0.000222	0.000866	CbGeAlD
Risperidone—Cough—Etoposide—brain cancer	0.000221	0.000658	CcSEcCtD
Risperidone—Constipation—Temozolomide—brain cancer	0.000221	0.000658	CcSEcCtD
Risperidone—Pain—Temozolomide—brain cancer	0.000221	0.000658	CcSEcCtD
Risperidone—ABCB1—medulla oblongata—brain cancer	0.00022	0.000861	CbGeAlD
Risperidone—Feeling abnormal—Carmustine—brain cancer	0.00022	0.000656	CcSEcCtD
Risperidone—Convulsion—Etoposide—brain cancer	0.000219	0.000653	CcSEcCtD
Risperidone—Hypertension—Etoposide—brain cancer	0.000218	0.000651	CcSEcCtD
Risperidone—Dizziness—Hydroxyurea—brain cancer	0.000218	0.000651	CcSEcCtD
Risperidone—Gastrointestinal pain—Carmustine—brain cancer	0.000218	0.000651	CcSEcCtD
Risperidone—CYP2D6—cerebellum—brain cancer	0.000217	0.000846	CbGeAlD
Risperidone—Chest pain—Etoposide—brain cancer	0.000215	0.000642	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000214	0.000638	CcSEcCtD
Risperidone—Discomfort—Etoposide—brain cancer	0.000213	0.000634	CcSEcCtD
Risperidone—Feeling abnormal—Temozolomide—brain cancer	0.000213	0.000634	CcSEcCtD
Risperidone—Abdominal pain—Carmustine—brain cancer	0.000211	0.000629	CcSEcCtD
Risperidone—Body temperature increased—Carmustine—brain cancer	0.000211	0.000629	CcSEcCtD
Risperidone—Gastrointestinal pain—Temozolomide—brain cancer	0.000211	0.000629	CcSEcCtD
Risperidone—Vomiting—Hydroxyurea—brain cancer	0.00021	0.000626	CcSEcCtD
Risperidone—Rash—Hydroxyurea—brain cancer	0.000208	0.000621	CcSEcCtD
Risperidone—Confusional state—Etoposide—brain cancer	0.000208	0.000621	CcSEcCtD
Risperidone—Dermatitis—Hydroxyurea—brain cancer	0.000208	0.00062	CcSEcCtD
Risperidone—Headache—Hydroxyurea—brain cancer	0.000207	0.000617	CcSEcCtD
Risperidone—Anaphylactic shock—Etoposide—brain cancer	0.000206	0.000615	CcSEcCtD
Risperidone—Infection—Etoposide—brain cancer	0.000205	0.000611	CcSEcCtD
Risperidone—Urticaria—Temozolomide—brain cancer	0.000205	0.000611	CcSEcCtD
Risperidone—Abdominal pain—Temozolomide—brain cancer	0.000204	0.000608	CcSEcCtD
Risperidone—Body temperature increased—Temozolomide—brain cancer	0.000204	0.000608	CcSEcCtD
Risperidone—Thrombocytopenia—Etoposide—brain cancer	0.000202	0.000603	CcSEcCtD
Risperidone—Tachycardia—Etoposide—brain cancer	0.000201	0.000601	CcSEcCtD
Risperidone—ABCB1—midbrain—brain cancer	0.000201	0.000787	CbGeAlD
Risperidone—Skin disorder—Etoposide—brain cancer	0.0002	0.000598	CcSEcCtD
Risperidone—Hyperhidrosis—Etoposide—brain cancer	0.0002	0.000595	CcSEcCtD
Risperidone—Anorexia—Etoposide—brain cancer	0.000197	0.000587	CcSEcCtD
Risperidone—Hypersensitivity—Carmustine—brain cancer	0.000197	0.000586	CcSEcCtD
Risperidone—ABCB1—spinal cord—brain cancer	0.000196	0.000768	CbGeAlD
Risperidone—Nausea—Hydroxyurea—brain cancer	0.000196	0.000585	CcSEcCtD
Risperidone—HTR2A—brain—brain cancer	0.000193	0.000754	CbGeAlD
Risperidone—Hypotension—Etoposide—brain cancer	0.000193	0.000575	CcSEcCtD
Risperidone—Asthenia—Carmustine—brain cancer	0.000191	0.000571	CcSEcCtD
Risperidone—Hypersensitivity—Temozolomide—brain cancer	0.00019	0.000567	CcSEcCtD
Risperidone—Paraesthesia—Etoposide—brain cancer	0.000185	0.000553	CcSEcCtD
Risperidone—Asthenia—Temozolomide—brain cancer	0.000185	0.000552	CcSEcCtD
Risperidone—Dyspnoea—Etoposide—brain cancer	0.000184	0.000549	CcSEcCtD
Risperidone—Somnolence—Etoposide—brain cancer	0.000183	0.000547	CcSEcCtD
Risperidone—Diarrhoea—Carmustine—brain cancer	0.000183	0.000545	CcSEcCtD
Risperidone—Pruritus—Temozolomide—brain cancer	0.000182	0.000544	CcSEcCtD
Risperidone—Decreased appetite—Etoposide—brain cancer	0.000179	0.000535	CcSEcCtD
Risperidone—Gastrointestinal disorder—Etoposide—brain cancer	0.000178	0.000531	CcSEcCtD
Risperidone—Fatigue—Etoposide—brain cancer	0.000178	0.000531	CcSEcCtD
Risperidone—ABCB1—endocrine gland—brain cancer	0.000177	0.000691	CbGeAlD
Risperidone—Dizziness—Carmustine—brain cancer	0.000176	0.000526	CcSEcCtD
Risperidone—Pain—Etoposide—brain cancer	0.000176	0.000526	CcSEcCtD
Risperidone—Constipation—Etoposide—brain cancer	0.000176	0.000526	CcSEcCtD
Risperidone—Diarrhoea—Temozolomide—brain cancer	0.000176	0.000526	CcSEcCtD
Risperidone—CYP2D6—brain—brain cancer	0.000176	0.000687	CbGeAlD
Risperidone—ABCB1—head—brain cancer	0.000175	0.000682	CbGeAlD
Risperidone—Dizziness—Temozolomide—brain cancer	0.000171	0.000509	CcSEcCtD
Risperidone—Feeling abnormal—Etoposide—brain cancer	0.00017	0.000507	CcSEcCtD
Risperidone—Vomiting—Carmustine—brain cancer	0.00017	0.000506	CcSEcCtD
Risperidone—Gastrointestinal pain—Etoposide—brain cancer	0.000169	0.000503	CcSEcCtD
Risperidone—Rash—Carmustine—brain cancer	0.000168	0.000502	CcSEcCtD
Risperidone—Dermatitis—Carmustine—brain cancer	0.000168	0.000501	CcSEcCtD
Risperidone—Headache—Carmustine—brain cancer	0.000167	0.000499	CcSEcCtD
Risperidone—Vomiting—Temozolomide—brain cancer	0.000164	0.000489	CcSEcCtD
Risperidone—Urticaria—Etoposide—brain cancer	0.000164	0.000489	CcSEcCtD
Risperidone—Abdominal pain—Etoposide—brain cancer	0.000163	0.000487	CcSEcCtD
Risperidone—Body temperature increased—Etoposide—brain cancer	0.000163	0.000487	CcSEcCtD
Risperidone—Rash—Temozolomide—brain cancer	0.000163	0.000485	CcSEcCtD
Risperidone—Dermatitis—Temozolomide—brain cancer	0.000162	0.000485	CcSEcCtD
Risperidone—Headache—Temozolomide—brain cancer	0.000162	0.000482	CcSEcCtD
Risperidone—ABCB1—central nervous system—brain cancer	0.000159	0.000623	CbGeAlD
Risperidone—Nausea—Carmustine—brain cancer	0.000159	0.000473	CcSEcCtD
Risperidone—ABCB1—cerebellum—brain cancer	0.000156	0.000609	CbGeAlD
Risperidone—Nausea—Temozolomide—brain cancer	0.000153	0.000457	CcSEcCtD
Risperidone—Hypersensitivity—Etoposide—brain cancer	0.000152	0.000453	CcSEcCtD
Risperidone—Asthenia—Etoposide—brain cancer	0.000148	0.000442	CcSEcCtD
Risperidone—Pruritus—Etoposide—brain cancer	0.000146	0.000435	CcSEcCtD
Risperidone—Diarrhoea—Etoposide—brain cancer	0.000141	0.000421	CcSEcCtD
Risperidone—Dizziness—Etoposide—brain cancer	0.000136	0.000407	CcSEcCtD
Risperidone—Vomiting—Etoposide—brain cancer	0.000131	0.000391	CcSEcCtD
Risperidone—Rash—Etoposide—brain cancer	0.00013	0.000388	CcSEcCtD
Risperidone—Dermatitis—Etoposide—brain cancer	0.00013	0.000388	CcSEcCtD
Risperidone—Headache—Etoposide—brain cancer	0.000129	0.000386	CcSEcCtD
Risperidone—ABCB1—brain—brain cancer	0.000127	0.000494	CbGeAlD
Risperidone—Nausea—Etoposide—brain cancer	0.000123	0.000366	CcSEcCtD
Risperidone—HRH1—Signaling Pathways—HES1—brain cancer	1.44e-05	0.000137	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—APC—brain cancer	1.44e-05	0.000136	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CG—brain cancer	1.44e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CG—brain cancer	1.43e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.42e-05	0.000135	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—IL2—brain cancer	1.42e-05	0.000135	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—APC—brain cancer	1.42e-05	0.000134	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.42e-05	0.000134	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HES1—brain cancer	1.41e-05	0.000134	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL2—brain cancer	1.4e-05	0.000133	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.4e-05	0.000133	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.4e-05	0.000133	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IRS2—brain cancer	1.4e-05	0.000133	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—IL2—brain cancer	1.4e-05	0.000132	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IRS2—brain cancer	1.39e-05	0.000132	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—EGFR—brain cancer	1.39e-05	0.000132	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.38e-05	0.000131	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.37e-05	0.00013	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.37e-05	0.00013	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—IDH1—brain cancer	1.36e-05	0.000129	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SPP1—brain cancer	1.36e-05	0.000129	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.35e-05	0.000128	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.35e-05	0.000128	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SPP1—brain cancer	1.34e-05	0.000127	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SPP1—brain cancer	1.33e-05	0.000126	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.33e-05	0.000126	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HES1—brain cancer	1.31e-05	0.000125	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—EGFR—brain cancer	1.31e-05	0.000124	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.31e-05	0.000124	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—RELA—brain cancer	1.3e-05	0.000124	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—ERBB2—brain cancer	1.29e-05	0.000123	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—brain cancer	1.29e-05	0.000123	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—RELA—brain cancer	1.29e-05	0.000123	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL2—brain cancer	1.29e-05	0.000123	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—EGFR—brain cancer	1.29e-05	0.000122	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.29e-05	0.000122	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—APC—brain cancer	1.28e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.28e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.27e-05	0.000121	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL2—brain cancer	1.27e-05	0.000121	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL2—brain cancer	1.27e-05	0.00012	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—RELA—brain cancer	1.27e-05	0.00012	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—ERBB2—brain cancer	1.26e-05	0.000119	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.25e-05	0.000119	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—RELA—brain cancer	1.25e-05	0.000118	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.24e-05	0.000118	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—ERBB2—brain cancer	1.24e-05	0.000117	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—APC—brain cancer	1.23e-05	0.000117	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.23e-05	0.000117	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.23e-05	0.000117	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—APC—brain cancer	1.23e-05	0.000117	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IRS2—brain cancer	1.23e-05	0.000116	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.22e-05	0.000115	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IRS2—brain cancer	1.21e-05	0.000115	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IRS2—brain cancer	1.21e-05	0.000114	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—APC—brain cancer	1.19e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.19e-05	0.000113	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—RELA—brain cancer	1.19e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.18e-05	0.000112	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.18e-05	0.000112	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—APC—brain cancer	1.18e-05	0.000112	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.18e-05	0.000112	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL2—brain cancer	1.17e-05	0.000111	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.17e-05	0.000111	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL2—brain cancer	1.17e-05	0.000111	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CG—brain cancer	1.16e-05	0.00011	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.16e-05	0.00011	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CCND1—brain cancer	1.14e-05	0.000108	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL2—brain cancer	1.14e-05	0.000108	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CCND1—brain cancer	1.14e-05	0.000108	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.13e-05	0.000107	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.13e-05	0.000107	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.12e-05	0.000107	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL2—brain cancer	1.12e-05	0.000106	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—RELA—brain cancer	1.12e-05	0.000106	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.12e-05	0.000106	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—ERBB2—brain cancer	1.12e-05	0.000106	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CCND1—brain cancer	1.11e-05	0.000105	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—RELA—brain cancer	1.11e-05	0.000105	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.1e-05	0.000104	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ERBB2—brain cancer	1.1e-05	0.000104	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.1e-05	0.000104	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CCND1—brain cancer	1.09e-05	0.000104	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.09e-05	0.000103	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—APC—brain cancer	1.08e-05	0.000103	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.08e-05	0.000103	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.08e-05	0.000103	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ENO2—brain cancer	1.08e-05	0.000102	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL2—brain cancer	1.07e-05	0.000102	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.07e-05	0.000102	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.07e-05	0.000101	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—APC—brain cancer	1.07e-05	0.000101	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.06e-05	0.000101	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—APC—brain cancer	1.06e-05	0.000101	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CG—brain cancer	1.06e-05	0.000101	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCND1—brain cancer	1.04e-05	9.91e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—APC—brain cancer	1.04e-05	9.91e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.04e-05	9.91e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CTNNB1—brain cancer	1.03e-05	9.81e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL2—brain cancer	1.01e-05	9.59e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—RELA—brain cancer	1e-05	9.48e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL2—brain cancer	9.97e-06	9.46e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—brain cancer	9.97e-06	9.45e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ERBB2—brain cancer	9.93e-06	9.42e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—brain cancer	9.9e-06	9.39e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—EGFR—brain cancer	9.88e-06	9.37e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—STAT3—brain cancer	9.87e-06	9.36e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCND1—brain cancer	9.85e-06	9.34e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—STAT3—brain cancer	9.8e-06	9.3e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CTNNB1—brain cancer	9.76e-06	9.25e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCND1—brain cancer	9.72e-06	9.22e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—EGFR—brain cancer	9.72e-06	9.22e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	9.71e-06	9.21e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APC—brain cancer	9.71e-06	9.21e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—EGFR—brain cancer	9.7e-06	9.2e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—brain cancer	9.69e-06	9.2e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—RELA—brain cancer	9.65e-06	9.15e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CTNNB1—brain cancer	9.63e-06	9.13e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—RELA—brain cancer	9.6e-06	9.11e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—STAT3—brain cancer	9.6e-06	9.11e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ERBB2—brain cancer	9.59e-06	9.09e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—brain cancer	9.54e-06	9.05e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ERBB2—brain cancer	9.54e-06	9.05e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—EGFR—brain cancer	9.52e-06	9.03e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—STAT3—brain cancer	9.45e-06	8.96e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RELA—brain cancer	9.34e-06	8.86e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ERBB2—brain cancer	9.28e-06	8.8e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RELA—brain cancer	9.19e-06	8.72e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MYC—brain cancer	9.17e-06	8.7e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ERBB2—brain cancer	9.13e-06	8.66e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MYC—brain cancer	9.11e-06	8.64e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—brain cancer	9.11e-06	8.64e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—STAT3—brain cancer	9.02e-06	8.55e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL2—brain cancer	9e-06	8.54e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—brain cancer	8.97e-06	8.51e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MYC—brain cancer	8.92e-06	8.46e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—brain cancer	8.91e-06	8.45e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—brain cancer	8.84e-06	8.39e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MYC—brain cancer	8.78e-06	8.33e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCND1—brain cancer	8.78e-06	8.32e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—brain cancer	8.72e-06	8.28e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	8.69e-06	8.24e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL2—brain cancer	8.69e-06	8.24e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL2—brain cancer	8.65e-06	8.2e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—brain cancer	8.59e-06	8.15e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—brain cancer	8.59e-06	8.14e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—STAT3—brain cancer	8.5e-06	8.07e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—brain cancer	8.47e-06	8.04e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RELA—brain cancer	8.47e-06	8.04e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCND1—brain cancer	8.47e-06	8.04e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCND1—brain cancer	8.43e-06	7.99e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ERBB2—brain cancer	8.42e-06	7.99e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL2—brain cancer	8.41e-06	7.98e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—STAT3—brain cancer	8.39e-06	7.96e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CTNNB1—brain cancer	8.39e-06	7.96e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—brain cancer	8.38e-06	7.95e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CTNNB1—brain cancer	8.35e-06	7.92e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RELA—brain cancer	8.34e-06	7.91e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RELA—brain cancer	8.32e-06	7.89e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ERBB2—brain cancer	8.28e-06	7.86e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL2—brain cancer	8.28e-06	7.85e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ERBB2—brain cancer	8.27e-06	7.84e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—brain cancer	8.2e-06	7.78e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—brain cancer	8.2e-06	7.77e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RELA—brain cancer	8.16e-06	7.74e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	8.12e-06	7.7e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ERBB2—brain cancer	8.11e-06	7.69e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—brain cancer	8.07e-06	7.65e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CG—brain cancer	8.03e-06	7.61e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	7.99e-06	7.58e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—brain cancer	7.9e-06	7.49e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—brain cancer	7.8e-06	7.4e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—brain cancer	7.73e-06	7.33e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—brain cancer	7.65e-06	7.26e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL2—brain cancer	7.63e-06	7.24e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—brain cancer	7.63e-06	7.23e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RELA—brain cancer	7.58e-06	7.19e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—STAT3—brain cancer	7.58e-06	7.19e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CG—brain cancer	7.56e-06	7.17e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ERBB2—brain cancer	7.54e-06	7.15e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—brain cancer	7.53e-06	7.14e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2—brain cancer	7.51e-06	7.12e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2—brain cancer	7.49e-06	7.11e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—brain cancer	7.48e-06	7.1e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—brain cancer	7.44e-06	7.05e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—brain cancer	7.39e-06	7e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—brain cancer	7.37e-06	6.99e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—brain cancer	7.35e-06	6.97e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.35e-06	6.97e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—brain cancer	7.33e-06	6.95e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—brain cancer	7.32e-06	6.94e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—brain cancer	7.31e-06	6.94e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—brain cancer	7.3e-06	6.93e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—brain cancer	7.28e-06	6.9e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.25e-06	6.87e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.23e-06	6.86e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—brain cancer	7.21e-06	6.84e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—brain cancer	7.17e-06	6.8e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—brain cancer	7.15e-06	6.78e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	7.1e-06	6.73e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—brain cancer	7.08e-06	6.71e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—brain cancer	7.04e-06	6.68e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—brain cancer	7.03e-06	6.67e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—brain cancer	6.96e-06	6.61e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—brain cancer	6.88e-06	6.53e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—brain cancer	6.88e-06	6.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—brain cancer	6.83e-06	6.48e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—brain cancer	6.8e-06	6.45e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—brain cancer	6.76e-06	6.41e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—brain cancer	6.66e-06	6.32e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—brain cancer	6.65e-06	6.3e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—brain cancer	6.61e-06	6.27e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	6.59e-06	6.25e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—brain cancer	6.58e-06	6.24e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—brain cancer	6.49e-06	6.16e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—brain cancer	6.48e-06	6.15e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—brain cancer	6.47e-06	6.14e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—brain cancer	6.43e-06	6.1e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—brain cancer	6.42e-06	6.09e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—brain cancer	6.4e-06	6.07e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.38e-06	6.05e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—brain cancer	6.37e-06	6.04e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—brain cancer	6.33e-06	6e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—brain cancer	6.32e-06	5.99e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—brain cancer	6.3e-06	5.98e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—brain cancer	6.25e-06	5.93e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—brain cancer	6.19e-06	5.87e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—brain cancer	5.97e-06	5.66e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—brain cancer	5.87e-06	5.57e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—brain cancer	5.86e-06	5.56e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—brain cancer	5.84e-06	5.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—brain cancer	5.8e-06	5.51e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—brain cancer	5.78e-06	5.48e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—brain cancer	5.75e-06	5.45e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—brain cancer	5.75e-06	5.45e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—brain cancer	5.74e-06	5.45e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—brain cancer	5.73e-06	5.43e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.62e-06	5.33e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—brain cancer	5.58e-06	5.29e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—brain cancer	5.55e-06	5.27e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—brain cancer	5.4e-06	5.12e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—brain cancer	5.34e-06	5.07e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—brain cancer	5.31e-06	5.04e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.22e-06	4.95e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CG—brain cancer	4.95e-06	4.69e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—brain cancer	4.9e-06	4.65e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—brain cancer	4.82e-06	4.57e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—brain cancer	4.81e-06	4.56e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—brain cancer	4.72e-06	4.48e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—brain cancer	4.39e-06	4.16e-05	CbGpPWpGaD
